News
Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results
Revenue Increases 48%, Gross profit increased 210% to $2.39 million andEarnings Rise over Same 2019 PeriodGenerics and Nutraceuticals Lead Expansion in EuropeRobotic Automations Enhance Margins and Reduce Costs CHICAGO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQΒ: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established EU distribution network, announced today record Third Quarter and Nine-Month results for the period ended September 30, 2020. ...
David Lowenstein Agrees to Join Cosmos Board of Directors
Seasoned Entrepreneur Has Taken Several Companies from Start-Up to IPO and has served on the boards of several NASDAQ and TSXV companies Appointment Follows Recent Board Selection of Peter Goldstein, Director and Principal of PGS Ventures B.V., as Executive Director CHICAGO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the company") (OTCQB: COSM), an international pharmaceutical wholesaler with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices and an extensive, established EU distribution network, today announced that seasoned entrepreneur David Lowenstein, 58, has agreed ...
Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion
Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion CHICAGO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has entered into an advisory agreement with PGS Ventures B.V. (PGS), an Amsterdam corporation (the Advisor), to identify and introduce the Company to prospective merger and acquisition candidates, potential sources of capital, and advise on senior exchange listing strategies. Peter Goldstein, the Director ...
Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results
CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six months ended June 30, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP). Financial Highlights for the three months ended June 30, 2020: -For the three months ended June 30, 2020, revenues increased by 50.6% to $12.8 million from $8.51 million in the same period in 2019. -Quarterly gross profits increased to $2.3 million from ...
Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results
CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year ended December 31, 2019 and the quarter ended March 31, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP). Financial Highlights for the year ended December 31, 2019: -Operating revenues increased in 2019 by 7.0% to $39.7 Million from $37.1 Million in 2018. -Gross profits improved by 52% year over year. For the twelve months ...
Photo
Steve Carr Managing Director

Join our mailing list to stay up to date.

Cosmos-logo